Adherence, healthcare resource utilization and Medicaid spending associated with once-monthly paliperidone palmitate versus oral atypical antipsychotic treatment among adults recently diagnosed with schizophrenia

被引：0
|
作者：
Dominic Pilon
Erik Muser
Patrick Lefebvre
Rhiannon Kamstra
Bruno Emond
Kruti Joshi
机构：
[1] Groupe d’analyse,
[2] Ltée,undefined
[3] Janssen Scientific Affairs,undefined
[4] LLC,undefined
来源：
BMC Psychiatry | / 17卷
关键词：
Oral Atypical Antipsychotics (OAA); Healthcare Resource Utilization; Mean Monthly Cost; Medical Cost Savings; Higher Pharmacy Costs;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Switching from oral atypical antipsychotic monotherapy to paliperidone palmitate once-monthly in non-acute patients with schizophrenia: A prospective, open-label, interventional study
    Andreas Schreiner
    Asaf Caspi
    Paul Bergmans
    Pierre Cherubin
    Sofia Keim
    Elsa Lara
    Irina Pinchuk
    Daniel Schuepbach
    Sajid Suleman
    Ludger Hargarter
    Psychopharmacology, 2017, 234 : 3 - 13
  • [42] Paliperidone Palmitate: A Breakthrough Treatment for Schizophrenia? A Review on Patient Adherence Levels, Healthcare Resource Utilization and Costs
    Bramante, Stefano
    Di Salvo, Gabriele
    Maina, Giuseppe
    Rosso, Gianluca
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2023, 19 : 519 - 530
  • [43] HEALTHCARE RESOURCE UTILIZATION AND COSTS AMONG ADULT SCHIZOPHRENIA PATIENTS USING ONCE-MONTHLY VERSUS TWICE-MONTHLY LONG ACTING ANTIPSYCHOTICS
    Benson, C.
    Alcusky, M.
    Pilon, D.
    Durkin, M.
    Xiao, Y.
    Thompson-Leduc, P.
    Lafeuille, M.
    Lefebvre, P.
    VALUE IN HEALTH, 2017, 20 (05) : A296 - A296
  • [44] ONCE MONTHLY PALIPERIDONE PALMITATE - TOLERABILITY AND TREATMENT RESPONSE IN RECENTLY DIAGNOSED VERSUS CHRONIC NON-ACUTE SCHIZOPHRENIA PATIENTS SWITCHED FROM PREVIOUSLY UNSUCCESSFUL TREATMENT WITH ORAL ANTIPSYCHOTICS
    Hargarter, Ludger
    Bergmans, Paul
    Cherubin, Pierre
    Rancans, Elmars
    Bez, Yasin
    Parellada, Eduardo
    Carpiniello, Bernardo
    Vidailhet, Pierre
    Schreiner, Andreas
    SCHIZOPHRENIA RESEARCH, 2014, 153 : S320 - S320
  • [45] ONCE MONTHLY PALIPERIDONE PALMITATE - TOLERABILITY AND TREATMENT RESPONSE IN RECENTLY DIAGNOSED VERSUS CHRONIC NON-ACUTE SCHIZOPHRENIA PATIENTS SWITCHED FROM PREVIOUSLY UNSUCCESSFUL TREATMENT WITH ORAL ANTIPSYCHOTICS
    Hargarter, L.
    Bergmans, P.
    Cherubin, P.
    Rancans, E.
    Bez, Y.
    Parellada, E.
    Carpiniello, B.
    Vidailhet, P.
    Schreiner, A.
    EUROPEAN PSYCHIATRY, 2014, 29
  • [46] ONCE MONTHLY PALIPERIDONE PALMITATE TOLERABILITY AND TREATMENT RESPONSE IN RECENTLY DIAGNOSED VERSUS CHRONIC NON-ACUTE SCHIZOPHRENIA PATIENTS SWITCHED FROM PREVIOUSLY UNSUCESFUL TREATMENT WITH ORAL ANTIPSYCHOTICS
    Hargarter, L.
    Bergmans, P.
    Cherubin, P.
    Rancans, E.
    Bez, Y.
    Parellada, E.
    Carpiniello, B.
    Vidailhet, P.
    Schreiner, A.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2014, 48 : 129 - 130
  • [47] Real-world evidence of improved healthcare utilization in patients with schizophrenia or schizoaffective disorder after early treatment of paliperidone palmitate once-monthly treatment in Hong Kong
    Choon, June W. Y.
    Wu, David B. C.
    Chong, H. Y.
    Lo, William T. L.
    Chong, Catherine S. Y.
    Chung, W. S.
    Chui, Eileena M. C.
    Tomlinson, Brian
    Lee, Vivian W. Y.
    Lee, S. C.
    Lee, Kenneth K. C.
    JOURNAL OF MEDICAL ECONOMICS, 2019, 22 (03) : 273 - 279
  • [48] Projecting the Potential Effect of Using Paliperidone Palmitate Once-Monthly and Once-Every-3-Months Long-Acting Injections Among Medicaid Beneficiaries with Schizophrenia
    Basu, Anirban
    Benson, Carmela
    Alphs, Larry
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2018, 24 (08): : 759 - +
  • [49] Adherence, persistence, and inpatient utilization among adult schizophrenia patients using once-monthly versus twice-monthly long-acting atypical antipsychotics
    Pilon, Dominic
    Alcusky, Matthew
    Xiao, Yongling
    Thompson-Leduc, Philippe
    Lafeuille, Marie-Helene
    Lefebvre, Patrick
    Benson, Carmela
    JOURNAL OF MEDICAL ECONOMICS, 2018, 21 (02) : 135 - 143
  • [50] Relapse and Treatment Adherence in Patients with Schizophrenia Switching from Paliperidone Palmitate Once-Monthly to Three-Monthly Formulation: A Retrospective Health Claims Database Analysis
    Li, Gang
    Keenan, Alexander
    Daskiran, Mehmet
    Mathews, Maju
    Nuamah, Isaac
    Orman, Camille
    Joshi, Kruti
    Singh, Arun
    Godet, Annabelle
    Pungor, Katalin
    Gopal, Srihari
    PATIENT PREFERENCE AND ADHERENCE, 2021, 15 : 2239 - 2248
12345